GDF11 promotes reverse cholesterol transport levels in vivo by enhancing the expression of ABCA1
Author:
Affiliation:

Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, China)

Clc Number:

R363

  • Article
  • | |
  • Metrics
  • |
  • Reference [13]
  • | | | |
  • Comments
    Abstract:

    Aim To explore the effect of growth differentiation factor 11 (GDF11) on macrophage reverse cholesterol transport and uncover the potential mechanism. Methods Mouse peritoneal macrophages were treated with oxidized low density lipoprotein (ox-LDL), GDF11 and activin receptor-like kinase 7 (ALK7) inhibitor SB431542 for 24 hours. The lipid accumulation was observed with oil red O staining, and the mRNA and protein expression levels of GDF11, ABCA1 and ABCG1 were determined by real-time PCR and Western blot. Mice were given intraperitoneal injection of exogenous GDF11. Peritoneal macrophages were labeled with 3H-cholesterol, then the labeled macrophages were injected into mice intraperitoneally. The mice feces were collected every 8 hours and the liver and blood samples of mice were gathered after 48 hours since cell injection. The radioactivity of 3H was detected to measure the reverse cholesterol transport level. Results After treated with ox-LDL for 24 hours, ox-LDL induced the accumulation of lipid in macrophage and inhibited the GDF11 mRNA and protein expression level. GDF11 treatment effectively inhibited the lipid accumulation in macrophage induced by ox-LDL. Exogenous GDF11 effectively induced macrophage ABCA1 mRNA expression and increased the cholesterol reverse transport level in vivo. However, after treated with GDF11 and ALK7 inhibitor SB431542, the inhibitory effect of GDF11 on intracellular lipid accumulation induced by ox-LDL was antagonized, and the upregulation of ABCA1 expression was also inhibited. Conclusion GDF11 regulates the expression of ABCA1 through ALK7, thus promoting the reverse transport of cholesterol in macrophage.

    Reference
    [1] Mendis S, Davis S, Norrving B.Organizational update:the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease.Stroke, 5,6(5):e121-e122.
    [2] Rader DJ, Daugherty A.Translating molecular discoveries into new therapies for atherosclerosis.Nature, 8,1(7181):904-913.
    [3] Loffredo FS, Steinhauser ML, Jay SM, et al.Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.Cell, 3,3(4):828-839.
    [4] Sinha M, Jang YC, Oh J, et al.Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.Science, 4,4(6184):649-652.
    [5] Katsimpardi L, Litterman NK, Schein PA, et al.Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors.Science, 4,4(6184):630-634.
    [6] Mei W, Xiang G, Li Y, et al.GDF11 protects against endothelial injury and reduces atherosclerotic lesion formation in apolipoprotein E-null mice.Mol Ther, 6,4(11):1 926-938.
    [7] Bochem AE, Van Wijk DF, Holleboom AG, et al.ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.Eur Heart J, 3,4(4):286-291.
    [8] Singaraja RR, Kang MH, Vaid K, et al.Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function.Circ Res, 9,5(2):138-147.
    [9] Herías V, Biessen EA, Beckers C, et al.Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.Arterioscler Thromb Vasc Biol, 5,5(1):79-86.
    [10] Meiler S, Baumer Y, Toulmin E, et al.MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.Arterioscler Thromb Vasc Biol, 5,5(2):323-331.
    [11] Nakashima M, Toyono T, Akamine A, et al.Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis.Mech Dev, 9,0(2):185-189.
    [12] McPherron AC, Lawler AM, Lee SJ.Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11.Nat Genet, 9,2(3):260-264.
    [13] Kim J, Wu HH, Lander AD, et al.GDF11 controls the timing of progenitor cell competence in developing retina.Science, 5,8(5730):1 927-930.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Xiong, ZHANG Ling, TAO Ling. GDF11 promotes reverse cholesterol transport levels in vivo by enhancing the expression of ABCA1[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(4):329-334.

Copy
Share
Article Metrics
  • Abstract:982
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:December 05,2017
  • Revised:April 05,2018
  • Online: May 04,2018
Article QR Code